乳腺癌新辅助化疗后病理完全缓解的识别:灰阶超声、剪切波弹性成像与MRI的比较
前瞻性队列研究纳入80例接受新辅助化疗的乳腺癌患者,于基线和治疗后行灰阶超声、剪切波弹性成像(SWE)及MRI检查。21例(26%)达病理完全缓解(pCR)。Emean下降百分比与灰阶超声直径下降百分比联合的AUC为0.92,与MRI的AUC 0.96相似(p=0.28)。
要点
- Emean下降百分比诊断pCR的AUC为0.89,灰阶超声直径下降百分比AUC为0.86。
- Emean与灰阶超声直径下降百分比联合的AUC为0.92,与MRI的AUC 0.96相似(p=0.28)。
- SWE联合灰阶超声在治疗结束时识别pCR的准确性与乳腺MRI相似。
核心结论
- SWE联合灰阶超声在治疗结束时识别乳腺癌新辅助化疗反应方面显示出前景,准确性相似于乳腺MRI;该技术可用于为新辅助化疗后的手术决策提供信息。
研究设计与样本
- 前瞻性队列研究,80例接受新辅助化疗的乳腺癌患者,于基线和治疗后行灰阶超声、SWE和MRI检查;每个病灶获取两个正交平面的4幅SWE图像;测量灰阶超声最大直径和MRI病灶强化最大直径;计算基线与治疗后MRI直径、灰阶超声直径及Emean、Emax、SD的下降百分比;采用ROC曲线和卡方检验分析。
诊断标准与关键数值
- pCR发生于80例中的21例(26%);Emean下降百分比诊断pCR的AUC为0.89;Emax下降百分比AUC为0.85;SD下降百分比AUC为0.75;灰阶超声直径下降百分比AUC为0.86;Emean与灰阶超声直径下降百分比联合AUC为0.92;MRI的AUC为0.96;联合AUC与MRI AUC比较p=0.28。
临床应用与阅片要点
- 作者认为SWE联合灰阶超声在治疗结束时识别新辅助化疗反应方面显示出前景,准确性相似于乳腺MRI;该技术可用于为新辅助化疗后的手术决策提供信息。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To assess the value of post-treatment shear-wave elastography (SWE) parameters (maximum stiffness [Emax], mean stiffness [Emean], and standard deviation [SD]) compared to greyscale ultrasonography (US) and magnetic resonance imaging (MRI) in identifying pathological complete response (pCR) to neoadjuvant chemotherapy (NACT) in breast cancer.
MATERIALS AND METHODS: In a prospective cohort study, 80 patients receiving NACT for breast cancer underwent baseline and post-treatment US, SWE, and MRI examinations. Four SWE images in two orthogonal planes were obtained. Maximum greyscale US diameter and maximum diameter of lesion enhancement on MRI were measured. Percentage reductions between baseline and post-treatment scans were calculated for MRI and greyscale US diameter, and Emean, Emax, and SD. The percentage reduction in Emean and US diameter were also analysed as a combination. Analysis was undertaken using receiver operating characteristic (ROC) curves and the chi-squared test.
RESULTS: pCR occurred in 21 of 80 (26%) women. The area under the ROC curve (AUC) for pCR of percentage reductions in Emean, Emax, SD, and greyscale US diameter were 0.89, 0.85, 0.75, and 0.86, respectively. The combination of percentage reductions in Emean and greyscale ultrasound diameter yielded an AUC of 0.92, which is similar to the AUC for MRI of 0.96 (p=0.28).
CONCLUSIONS: SWE combined with greyscale US shows promise for end-of-treatment identification of response to NACT in women with breast cancer, with accuracies similar to breast MRI. This technique could be used to inform surgical decision-making after NACT.
引用
- Evans A, Whelehan P, Thompson A, et al. Identification of pathological complete response after neoadjuvant chemotherapy for breast cancer: comparison of greyscale ultrasound, shear wave elastography, and MRI. Clin Radiol. 2018. PMID: 29980324. doi:10.1016/j.crad.2018.05.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。